Cell MedX Corp. announced that Ms. Jean Arnett was appointed to the company's Board of Directors and as the Company's Vice President of Corporate Strategy, while Mr. Bradley Hargreaves was appointed as the company's Vice President of Technology and Operations. Yanika Silina was appointed as the company's Chief Financial Officer, Treasurer and Secretary.

Frank McEnulty will continue to act as a director of the company and as the company's Chief Executive Officer and President. Ms. Arnett has been the director of strategic planning for XC Velle Institute Inc. since 2009. Bradley Hargreaves' background is in engineering, with three operations journeyman tickets.

During the past eight years Mr. Hargreaves has researched the Technology and designed and improved treatment protocols for the treatment of diabetes and related ailments. Mr. Hargreaves will provide his expertise and technical support to the Company's research and development team and will oversee the continuous development of the project. Mr. Hargreaves has been the director of operations and principal of XC Velle Institute Inc. since 2009.

Yanika Silina has worked in the accounting field for the past eight years. Since July 2008, Ms. Silina has been an accountant with Da Costa Management Corp. Ms. Silina received her Diploma in Accounting in 2011 and currently is working towards her CMA /CPA designation.